Parallax Volatility Advisers’s Haemonetics HAE Stock Holding History

Parallax Volatility Advisers’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-966	Closed	-$115K	–	1472
2020 Q4	$115K	Buy	+966	New	+$104K	﹤0.01%	1946
2020 Q3	–	Sell	-724	Closed	-$65K	–	3083
2020 Q2	$65K	Buy	+724	New	+$73.1K	﹤0.01%	2468
2019 Q1	–	Sell	-29	Closed	-$3K	–	3259
2018 Q4	$3K	Buy	+29	New	+$3.05K	﹤0.01%	2631
2018 Q3	–	Sell	-126	Closed	-$11K	–	2973
2018 Q2	$11K	Buy	+126	New	+$10.6K	﹤0.01%	1741
2018 Q1	–	Sell	-8,064	Closed	-$468K	–	3056
2017 Q4	$468K	Buy	+8,064	New	+$425K	﹤0.01%	1572

Other funds holding HAE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parallax Volatility Advisers's HAE Position: Q1 2021 in Review

Parallax Volatility Advisers sold out of Haemonetics (HAE) in Q1 2021, closing a stake of 966 shares — an estimated $115K sold.

Parallax Volatility Advisers first reported a position in HAE in Q4 2017 and held it in 5 quarters. The position peaked at $468K in Q4 2017. 296 funds tracked by Wall St. Rank hold HAE as of Q1 2021.

Parallax Volatility Advisers reported no remaining Haemonetics position as of Q1 2021 after selling out during the quarter.
Parallax Volatility Advisers sold 966 Haemonetics shares in Q1 2021, an estimated $115K.
Parallax Volatility Advisers first reported a position in Haemonetics in Q4 2017 and held it in 5 quarters.
Parallax Volatility Advisers's Haemonetics position peaked at $468K in Q4 2017.
296 funds tracked by Wall St. Rank held Haemonetics as of Q1 2021.

Based on Parallax Volatility Advisers's 13F filing for Q1 2021, filed 14 May 2021.